Navigation Links
New Report 'Looking at Chiral Technologies' Analyzes the Global,Market Growth Forecasts Driven By Two Very Important Components as,Single Isomer Drugs and Single Enantiomer Pharmaceuticals

DUBLIN, Ireland--(BUSINESS WIRE)--Jun 21, 2007 - Research and Markets (http://www.researchandmarkets.com/reports/c60415) has announced the addition of Looking at Chiral Technologies to their offering.

The advancements in molecular research and continued untiring efforts of the research industry to develop better more precisely applicable Pharmaceuticals as well as agro compounds would have not been possible without the advent of Chiral technologies and their applications.

The usage of chiral molecules is at the very centre of this technological revolution when coupled with the application of chiral technologies as: Chiral Pool, Resolution, Biocatalysts, or asymmetric analysis creates the required compounds. The majority of development activity is routed through fine chemical companies which are additionally trying to upgrade their capabilities in order to provide to the entire portfolio of pharmaceutical drugs for application in the consumer arena.

Such ramping up of operations by companies in order to develop and upgrade basic molecules for wide ranging applications is also bringing the focus of chiral technologies into the development of clinical cures.

This report - Looking at Chiral Technologies - introduces the concept of Chiral Technologies supplementing it with its variants and explaining the actions undertaken by the industry towards developing such compounds jointly and deriving common benefits of clinical nature. The report also analyzes the global market growth forecasts driven by two very important components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals which are synthesized in bulk nature which are contributing to deriving drug streams worldwide.

The report explains the sales of Single Enantiomer pharma on a YOY basis, which is being controlled by certain regulatory constraints. The report also presents an insight on the synergies developed by the industr
'"/>




Page: 1 2

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
(Date:7/23/2008)... publication in July print edition of Clinical ...DIANAPOLIS, July 23 /- A Roche Diagno...N-terminal pro-B-type natriuretic peptide,(NT-proB...risk,stratification in predicting the risk of card...ted with non-steroidal anti-inflammatory drugs of,...
(Date:7/23/2008)...3 /- InCode BioPharmaceutics, Inc.,a...ced preclinical test,results demonstrating the uti...eatment of the rare chronic blood disorder paroxys...esults will be presented at the XXII,International...ber 28,2008., The only treatment currently avail...
(Date:7/22/2008).../- Nonin Medical, a leading innovator...an 20 years, has entered,the clinical testing phas...onal oxygen saturation. Today,s most common applic...ring of the regional blood oxygenation,in the brai...utcomes from an ongoing clinical study at the,Duke...
(Date:7/22/2008)... Lantus(R) and Apidra(R) Resulted in Significant, ..., Whatever the Algorithm ...ire/ -- Results from the "Adjust to,Target in Type...arbohydrate,Counting for Adjustment of Mealtime In...ican Diabetes Association,s (ADA) medical journal,...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Almost Family Announces Expansion of Revolving Credit Facility 7573 1Almost Family Announces Expansion of Revolving Credit Facility 7573 2Almost Family Announces Expansion of Revolving Credit Facility 7573 3Capital BlueCross HMO Plan is Ranked No 1 in Pennsylvania for Member Satisfaction 7571 1Capital BlueCross HMO Plan is Ranked No 1 in Pennsylvania for Member Satisfaction 7571 27 or 8 Hours of Sleep Best for Health 7569 1Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing 2067 1Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing 2067 2
...earch and Treatment of Rare but Devastating,Condit...ry University London,and the University of Leicest...ntial breakthrough in the treatment of a rare but,...dren and young,people. , In a world first, the cli...ave already treated one patient with promising,res...
...tner Forest Laboratories, Inc. Today,Announced the...cute,Ischemic Stroke) Study with the Compound Desm...N AG (Frankfurt Stock,Exchange, Prime Standard: PA...YSE: FRX) today announced topline results of,the D...y with the,compound Desmoteplase. The Phase III st...
Other Medicine Technology:World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
... saying that more family physicians are needed to ... University// of Utah School of Medicine and the U... needs of the population were increasing, so new h..."Family Physician Workforce Reform: Recommendation...
...pital have discovered that a protein called ABCB6 ...hat is key to the ability// of red blood cells to ... and of cells to extract energy from nutrients. T...ABCB6 is lodged within the outer membrane of the c...
...ublic health interventions can cost hundreds of li...n this week’s BMJ argue that, if the science is go...domised controlled trials are usually required bef... But in 2003, the BMJ published an article about t...
...stitute of MIT and Harvard announced today the dev...an connect human diseases// with potential drugs t...k in human cells. Called the 'Connectivity Map,' t...tember 29 issue of Science and in separate publica...
Other Medicine News:Health News:Call To Increase Family Physicians 2Health News:Call To Increase Family Physicians 3Health News:ABCB6 Is Key to Production of Heme in Hemoglobin 2Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 2Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 3
SUR-FIT Natura® Urostomy Pouch
New Image Urostomy Pouch, Beige
New Image Sterile Drainable Kits with Lock 'n Roll
New Image Pre-sized Flextend Skin Barrier, Floating Flange, with Tape
Medicine Products: